Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma

Gynecologic Oncology

Volumn 120, Issue 2, 2011, Pages 179-184

  Obermair, Andreas ^a,b   Mileshkin, Linda ^c   Bolz, Katharina ^a,d   Kondalsamy Chennakesavan, Srinivas ^a   Cheuk, Robyn ^b   Vasey, Paul ^b   Wyld, David ^b   Goh, Jeffrey ^b   Nicklin, James L ^b   Perrin, Lewis C ^e   Sykes, Peter ^f   Janda, Monika ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e Mater Hospital   (Australia)

^f UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Carboplatin; Feasibility; Paclitaxel; Radiotherapy; Uterine papillary serous carcinoma

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLEEDING; BLOOD TOXICITY; BONE MARROW TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEBRILE NEUTROPENIA; GASTROINTESTINAL SYMPTOM; HUMAN; HYSTERECTOMY; INFECTION; LYMPH NODE DISSECTION; LYMPHATIC SYSTEM INFECTION; METABOLIC DISORDER; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL DISEASE; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OMENTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PAPILLARY CARCINOMA; PELVIS; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RECURRENT DISEASE; REPRODUCTIVE TOXICITY; SALPINGOOOPHORECTOMY; SEQUENTIAL RADICAL PELVIC RADIOTHERAPY; SKIN TOXICITY; SYNDROME; THERAPY DELAY; UPPER RESPIRATORY TRACT INFECTION; UTERINE PAPILLARY SEROUS CARCINOMA; UTERUS CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 79251596941     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.10.039     Document Type: Article

References (29)

1. L.J. Havrilesky, A.A. Secord, V. Bae-Jump, T. Ayeni, B. Calingaert, D.L. Clarke-Pearson, A. Berchuck, and P.A. Gehrig Outcomes in surgical stage I uterine papillary serous carcinoma Gynecol Oncol 105 2007 677 682
2. Schwartz PE, Mundt AJ. Uterine papillary serous and clear cell cancer. Up To Date 2008;version 16.3.
3. H. Goldberg, R.C. Miller, R. Abdah-Bortnyak, M. Steiner, F. Yildiz, A. Meirovitz, S. Villa, P.M. Poortmans, D. Azria, J. Zidan, M. Ozsahin, U. Abacioglu, D.G. Gold, A. Amit, O. Lavie, I.L. Atahan, and A. Kuten Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN) Gynecol Oncol 108 2008 298 305
4. B.M. Slomovitz, T.W. Burke, P.J. Eifel, L.M. Ramondetta, E.G. Silva, A. Jhingran, J.C. Oh, E.N. Atkinson, R.R. Broaddus, D.M. Gershenson, and K.H. Lu Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases Gynecol Oncol 91 2003 463 469
5. W.M. Christopherson, R.C. Alberhasky, and P.J. Connelly Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma Cancer 49 1982 1511 1523
6. V.M. Abeler, I.B. Vergote, K.E. Kjorstad, and C.G. Trope Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern Cancer 78 1996 1740 1747
7. M.L. Carcangiu, and J.T. Chambers Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival Int J Gynecol Pathol 14 1995 30 38
8. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and R. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma Am J Surg Pathol 6 1982 93 108
9. Goff B.A. Surgical treatment of unusual endometrial cancer: American Society of Clinical Oncology 2004 Educational Book 40th Annual meeting 2004
10. W.T. Creasman, F. Odicino, P. Maisonneuve, U. Beller, J.L. Benedet, A.P. Heintz, H.Y. Ngan, M. Sideri, and S. Pecorelli Carcinoma of the corpus uteri J Epidemiol Biostat 6 2001 47 86
11. Y.L. Ren, H.Y. Wang, L. Shen, and W.T. Yang Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma Zhonghua Fu Chan Ke Za Zhi 41 2006 817 821
12. A.L. Fields, M.H. Einstein, A.P. Novetsky, J. Gebb, and G.L. Goldberg Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC) Gynecol Oncol 108 2008 201 206
13. A.J. Fakiris, D.H. Moore, S.R. Reddy, K.Y. Look, C.T. Yiannoutsos, M.E. Randall, and H.R. Cardenes Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study Gynecol Oncol 96 2005 818 823
14. A.S. Zigmond, and R.P. Snaith The hospital anxiety and depression scale Acta Psychiatr Scand 67 1983 361 370
15. Radloff L. The CES-D scale: a self-report depression scale for research in the general population Appl Psychol Meas 1977 385 401
16. M. Janda, T. DiSipio, C. Hurst, D. Cella, and B. Newman The Queensland cancer risk study: general population norms for the functional assessment of cancer therapy-general (FACT-G) Psychooncology 18 2009 606 614
17. Beckerman H., Roebroeck M.E., Lankhorst G.J., Becher J.G., Bezemer P.D., and Verbeek A.L. Smallest real difference, a link between reproducibility and responsiveness Qual Life Res 10 2001 571 578
18. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
19. F. Salaffi, A. Stancati, C.A. Silvestri, A. Ciapetti, and W. Grassi Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale Eur J Pain 8 2004 283 291
20. K.W. Wyrwich, M. Bullinger, N. Aaronson, R.D. Hays, D.L. Patrick, and T. Symonds Estimating clinically significant differences in quality of life outcomes Qual Life Res 14 2005 285 295
21. A.B. Olawaiye, and D.M. Boruta II Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review Gynecol Oncol 113 2009 277 283
22. A.P. Vaidya, R. Littell, C. Krasner, and L.R. Duska Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel Int J Gynecol Cancer 16 Suppl 1 2006 267 272
23. D. Faratian, A. Stillie, R.M. Busby-Earle, V.J. Cowie, and H. Monaghan A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome Int J Gynecol Cancer 16 2006 972 978
24. G. Sutton, J.H. Axelrod, B.N. Bundy, T. Roy, H. Homesley, R.B. Lee, P.A. Gehrig, and R. Zaino Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group Gynecol Oncol 100 2006 349 354
25. T. Pearman Quality of life and psychosocial adjustment in gynecologic cancer survivors Health Qual Life Outcomes 1 2003 33
26. J.R. Carter, M.D. Chen, J.M. Fowler, L.F. Carson, and L.B. Twiggs The effect of prolonged cycles of chemotherapy on quality of life in gynaecologic cancer patients J Obstet Gynaecol Res 23 1997 197 203
27. S.K. Lutgendorf, B. Anderson, N. Rothrock, R.E. Buller, A.K. Sood, and J.I. Sorosky Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer Cancer 89 2000 1402 1411
28. A.N. Fader, C. Nagel, A.E. Axtell, K.M. Zanotti, J.L. Kelley, K.N. Moore, A.A. Secord, C.S. Walsh, W.K. Huh, P.A. Gehrig, H. Gibbons, P.G. Rose, L.J. Havrilesky, E. Tuller, R.D. Drake, J. Bottsford-Miller, and D.M. O'Malley Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes Gynecol Oncol 112 2009 558 562
29. N.E. Tchabo, S. McCloskey, T.L. Mashtare, C. Andrews, A.K. Singh, P. Mhawech-Fauceglia, K. Odunsi, S. Lele, and W. Jaggernauth Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006 Gynecol Oncol 115 2009 249 256